Changes to the Animal Welfare Act Affecting Animal Research Facilities

December 6, 2022

Rat sitting in the palm of a gloved hand

Does your organization conduct or outsource testing to an Animal Research Facility?  If so, are you aware of the changes that have been implemented to the AWA (Animal Welfare Act) by the Animal and Plant Health Inspection Service (APHIS) and what this means for your facility or research study?

Final Rule Amending Animal Welfare Act

On November 23, 2021, the United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced a final rule amending the AWA regulations to help reduce duplicative requirements and the administrative burden on research facilities while continuing to ensure human animal care.  This change was in response to the requirements under the 21st Century Cures Act, which directs the USDA to work with the Food and Drug Administration (FDA) and the National Institute of Health (NIH) to complete a review of regulations and policies for the care and use of laboratory animals.  The changes apply to registered facilities that use animals to conduct research, teaching, testing and experimentation and the final rule went into effect on December 27, 2021.

What Does This Mean for Your Facility?

Changes implemented include:

  • Eliminating the redundant requirement to update facility registration every three years. Facilities are already required to notify APHIS of any changes affecting its status of a research facility, within ten days after making a notifiable change.
  • Clarifying the terms for registration and termination. Clearly stating that a research facility registration will no longer be valid if a research facility voluntarily requests registration termination; fails to file an annual report of animal use for two consecutive years, or other changes in business status.
  • Eliminating the requirement for a research facility that has not engaged animal use for a at least two years to request being placed on an inactive status.
  • Replacing annual review of protocols already approved by the IACUC with a requirement to conduct a complete review of IACUC-approved protocols at 3-year intervals instead. Resulting in a protocol remaining valid for three years after IACUC approval.  This harmonizes APHIS’ protocols with that of the NIH into one timeline.
  • Eliminating the requirement for facility chief executive officer or institutional official signatures on the Annual Report to guard against identity theft.

All of these changes are implemented at the Institutional level and are centered around minimizing administrative burden and duplicative requirements from a facility’s Institutional Animal Care and Use Committee (IACUC).  These changes are a great example of how regulations can be harmonized to reduce facility obligations and improve compliance; exemplifying not all changes are bad.

Get Help for Your Animal Research Projects

Clinical and nonclinical research is a revolving door of new and revised regulations.  At ProPharma Group our team of experts can help your facility stay in front of such regulations.  Contact us today to assist in this constantly evolving environment.

TAGS:

Illustration of a magnifying glass enlarging a checklist.

July 8, 2022

CVM GFI #245 - Hazard Analysis and Risk-Based Preventive Controls for Food for Animals

July 2022 The purpose of this guidance is to help animal food facilities develop a food safety plan that complies with FDA’s Hazard Analysis and Risk-Based Preventive Controls requirements....

September 30, 2021

EMA Takes Steps to Minimize Animal Testing During Product Development

On Wednesday, September 29th, EMA announced the implementation of new measures indented to replace, reduce, and refine animal use in the development, manufacturing, and testing of human and...

Gloved hands creating a compounded drug in a bowl.

Outsourcing Facilities and GMP: A New Relationship

Compounding is a practice in which a licensed pharmacist, a licensed physician, or, in the case of an outsourcing facility, a person under the supervision of a licensed pharmacist, combines, mixes,...